News Articles for AusCann Group Holdings

Altura Mining directors Allan Buckler and Paul Mantell and AusCann Holdings directors Mal Washer and Harry Karelis have been among a group of major Western Australian investors to have the value of their portfolios hit as markets have fluctuated in recent weeks.

Clinical trials company Zelda Therapeutics aims to pave the way for the use of medicinal cannabis to treat a range of disorders.

Fortescue Metals Group founder and chair Andrew Forrest has seen his stake in the miner increase $249 million in value over the past four weeks, according to data on directors' shareholdings tracked by Business News.

The strong performance of the Business News index of 30 local companies designed to track the state's economy implies good years ahead for WA.

Medicinal cannabis producers have welcomed the Australian government's decision to approve exports of their products.

Harry Karelis has resigned as executive director of AusCann Holdings in order to concentrate on other business ventures.

A medical cannabis company focused on animal health has announced plans to list on the ASX, while two other companies - including a pearling business - have made movements in the pharmaceutical space.

Shares in Perth-based AusCann Group Holdings surged on news it had secured a licence to manufacture and supply medical cannabis.

SPECIAL REPORT: Backdoor-listed technology businesses and mining hopefuls have joined the state's top performers in financial year 2016 in Business News's annual analysis of total shareholder returns.

The chief executive of medical cannabis company AusCann Group Holdings has received a boost to her salary package, which will net her about $360,000 in cash for FY17.

The directors of medicinal cannabis companies Creso Pharma and AusCann Group Holdings have reaped windfall gains worth $13 million after the vesting of performance rights and performance shares.

AusCann Group Holdings has confirmed a $12 million capital raising to fund the development and manufacture of medical cannabis products in Australia.

Perth company AusCann Group Holdings has become the seventh applicant to gain regulatory approval to cultivate medicinal cannabis in Australia, with the news lifting its share price by 17 per cent today.

Newly appointed chief executives in WA are on substantially lower salary packages compared with recent years, a Business News survey has found.

Medical cannabis company AusCann Group Holdings has wrapped up its first day of trading on the ASX after completing a reverse takeover of TW Holdings.

Murdoch University has partnered with a Perth company which plans to use cannabis as a medicinal product, a day after scientists from the University of Western Australia said cannabis use could damage a person's DNA.

Medical cannabis hopeful MGC Pharmaceuticals has upped its capital raising to $5 million after its initial $3.5 million raising closed oversubscribed.

Shares in TW Holdings slumped sharply today after it announced a backdoor listing of medical cannabis company AusCann Group Holdings, the second deal of this type involving members of the Washer family.